Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Overgaard

Showing results (221-230 of 389) with videos related to

Pageof 39
Sort By:
International Journal of Radiation Biology|April 26, 2007
Reproductive death of cancer cells induced by femtosecond laser pulsesJan Thøgersen, Cindy S Knudsen, Alice Maetzke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 15, 2025
The fractionation effect on proton RBE in a late normal tissue damage model in vivoCathrine Bang Overgaard, Fardous Reaz, Per Poulsen, et al.
Anticancer Research|November 29, 2023
<i>In Vitro</i> Characterization of the Bacteria-derived Hypoxia-selective Cytotoxin BE-43547Morten Busk, Peter P Eggertsen, Jens Overgaard, et al.
Plos One|June 26, 2008
Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancerBo Eskerod Madsen, Eliana Marisa Ramos, Mathieu Boulard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2005
TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancerChristian Nicolaj Andreassen, Jan Alsner, Jens Overgaard, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 18, 2015
Collagen fragment biomarkers as serological biomarkers of lean body mass - a biomarker pilot study from the DAHANCA25B cohort and matched controlsAnders Nedergaard, Ulrik Dalgas, Hanne Primdahl, et al.
Nature Reviews. Cancer|March 25, 2016
Radiation oncology in the era of precision medicineMichael Baumann, Mechthild Krause, Jens Overgaard, et al.
The American Journal of Pathology|October 28, 2003
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomasBirgitte Vrou Offersen, Boye Schnack Nielsen, Gunilla Høyer-Hansen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 15, 2022
Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trialMarie Overgaard, Hanne Melgaard Nielsen, Trine Tramm, et al.
Acta Oncologica (Stockholm, Sweden)|December 6, 2017
Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaborationBent Ejlertsen, Birgitte Vrou Offersen, Jens Overgaard, et al.
Pageof 39

Showing results (221-230 of 389) with videos related to

Sort By:
Pageof 39
International Journal of Radiation Biology|April 26, 2007
Reproductive death of cancer cells induced by femtosecond laser pulsesJan Thøgersen, Cindy S Knudsen, Alice Maetzke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 15, 2025
The fractionation effect on proton RBE in a late normal tissue damage model in vivoCathrine Bang Overgaard, Fardous Reaz, Per Poulsen, et al.
Anticancer Research|November 29, 2023
<i>In Vitro</i> Characterization of the Bacteria-derived Hypoxia-selective Cytotoxin BE-43547Morten Busk, Peter P Eggertsen, Jens Overgaard, et al.
Plos One|June 26, 2008
Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancerBo Eskerod Madsen, Eliana Marisa Ramos, Mathieu Boulard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2005
TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancerChristian Nicolaj Andreassen, Jan Alsner, Jens Overgaard, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 18, 2015
Collagen fragment biomarkers as serological biomarkers of lean body mass - a biomarker pilot study from the DAHANCA25B cohort and matched controlsAnders Nedergaard, Ulrik Dalgas, Hanne Primdahl, et al.
Nature Reviews. Cancer|March 25, 2016
Radiation oncology in the era of precision medicineMichael Baumann, Mechthild Krause, Jens Overgaard, et al.
The American Journal of Pathology|October 28, 2003
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomasBirgitte Vrou Offersen, Boye Schnack Nielsen, Gunilla Høyer-Hansen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 15, 2022
Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trialMarie Overgaard, Hanne Melgaard Nielsen, Trine Tramm, et al.
Acta Oncologica (Stockholm, Sweden)|December 6, 2017
Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaborationBent Ejlertsen, Birgitte Vrou Offersen, Jens Overgaard, et al.
Pageof 39